BLOOD MALL: RETAPED

Ollie Hall · 2026 · $1.99 · Action · deal grade B

Measured on 2026-09-23 19:35 UTC, 12 days ago. The whole catalog is re-measured daily; a game that just launched can move fast between passes.

• Estimated net residual revenue: $552 to $828 per month
• Opportunity: $897 per month at x1.30 dormancy
• Estimated lifetime owners: 11.4k
• 95% positive across 318 reviews · 41.4 reviews/month

Why it's flagged

• Developer active, last post 3 months ago
• Store page localized in only 1 language(s)
• Last discounted 0 months ago, 5 sales in the last 12 months

Analyst notes (AI-assisted)

Note written 2026-09-06; the live figures above take precedence over any numbers in it.

A short-form 80s-style dinosaur slasher with PSX-inspired aesthetics and lo-fi horror atmosphere, built as a spiritual successor to browser horror.

Blood Mall: Retaped occupies a niche but genuine position in indie horror; its 94% positive score and moderate replay value suggest a loyal cult following despite minimal player concurrency. The game sits dormant in terms of marketing and update cadence (no discounts, no developer posts in 2+ months), yet still accrues steady residual revenue. Most relevant for publishers seeking to expand catalog depth in retro-horror or for the original studio to coordinate a sequel marketing push, not for acquisition. Community enthusiasm for a sequel is explicit in reviews. Most realistic play: publishing.

• Risk: Ultra-short play sessions (0.9 median hours) and niche retro-horror aesthetic limit mainstream appeal and repeat monetization; audience self-selects for enthusiasts only.
• Risk: Single-language localization (English only despite international review base) represents untapped retention opportunity but signals low ongoing investment.
• Risk: Developer (one-title studio via DOSMan Publishing) shows minimal post-launch engagement; sustained marketing or live-ops momentum unlikely without external partner.

This case as Markdown · Estimates carry ±30-50% error per title.